Effect of nut consumption on oxidative stress and the endothelial function in metabolic syndrome

Clinical Nutrition

Volumn 29, Issue 3, 2010, Pages 373-380

  Lopez Uriarte Patricia P ^a   Nogués, Rosa ^b   Saez, Guillermo ^c   Bulló, Mònica ^a,d   Romeu, Marta ^b   Masana, Lluís ^e   Tormos, Carmen ^c   Casas Agustench, Patricia ^a   Salas Salvadó, Jordi ^a,d  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

^d Instituto de Salud Carlos III   (Spain)

^e FACULTAT DE MEDICINA I CIÈNCIES DE LA SALUT   (Spain)

Author keywords

Antioxidant capacity; DNA damage; Endothelial function; Lipid oxidation; Metabolic syndrome; Nuts

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8 ISOPROSTANE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; 8-OXO-7-HYDRODEOXYGUANOSINE; ANTIOXIDANT; BIOLOGICAL MARKER; DEOXYGUANOSINE; ISOPROSTANE DERIVATIVE; LOW DENSITY LIPOPROTEIN; UNSATURATED FATTY ACID;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BODY COMPOSITION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DNA DAMAGE; ENDOTHELIUM CELL; FEMALE; FOOD INTAKE; HUMAN; INSULIN RESISTANCE; LIPID OXIDATION; MALE; METABOLIC SYNDROME X; NUT; OBESITY; OXIDATIVE STRESS; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TONOMETRY; URINARY EXCRETION; WAIST CIRCUMFERENCE; ADOLESCENT; ANALOGS AND DERIVATIVES; ARTERY; BLOOD; CHEMISTRY; DIET; DIET THERAPY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; URINE; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIOXIDANTS; ARTERIES; BIOLOGICAL MARKERS; DEOXYGUANOSINE; DIET; DNA DAMAGE; ENDOTHELIUM, VASCULAR; FATTY ACIDS, UNSATURATED; HUMANS; ISOPROSTANES; LIPOPROTEINS, LDL; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NUTS; OXIDATIVE STRESS; VASCULAR RESISTANCE; YOUNG ADULT;

EID: 77953540585     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2009.12.008     Document Type: Article

References (50)

1. Kelly J.H., Sabate J. Nuts and coronary heart disease: an epidemiological perspective. Br J Nutr 2006, 96:S61-S67.
2. Mukuddem-Petersen J., Oosthuizen W., Jerling J.C. A systematic review of the effects of nuts on blood lipid profiles in humans. J Nutr 2005, 135:2082-2089.
3. Johnson R.K., Kennedy E. The 2000 dietary guidelines for americans: what are the changes and why were they made? the dietary guidelines advisory committee. J Am Diet Assoc 2000, 100:769-774.
4. Krauss R.M., Eckel R.H., Howard B., Appel L.J., Daniels S.R., Deckelbaum R.J., et al. AHA dietary guidelines: revision 2000: a statement for healthcare professionals from the nutrition committee of the American heart association. Circulation 2000, 102:2284-2299.
5. Kris-Etherton P.M., Yu-Poth S., Sabate J., Ratcliffe H.E., Zhao G., Etherton T.D. Nuts and their bioactive constituents: effects on serum lipids and other factors that affect disease risk. Am J Clin Nutr 1999, 70:504S-511S.
6. Reaven P., Parthasarathy S., Grasse B.J., Miller E., Steinberg D., Witztum J.L. Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects. J Clin Invest 1993, 91:668-676.
7. Berry E.M., Eisenberg S., Haratz D., Friedlander Y., Norman Y., Kaufmann N.A., et al. Effects of diets rich in monounsaturated fatty acids on plasma lipoproteins-the Jerusalem nutrition study: high MUFAs vs high PUFAs. Am J Clin Nutr 1991, 53:899-907.
8. Thomas M.J., Rudel L.L. Dietary fatty acids, low density lipoprotein composition and oxidation and primate atherosclerosis. J Nutr 1996, 126:1058S-1062S.
9. Wu L.L., Chiou C.C., Chang P.Y., Wu J.T. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 2004, 339:1-9.
10. Zambon D., Sabate J., Munoz S., Campero B., Casals E., Merlos M., et al. Substituting walnuts for monounsaturated fat improves the serum lipid profile of hypercholesterolemic men and women. A randomized crossover trial. Ann Intern Med 2000, 132:538-546.
11. Iwamoto M., Imaizumi K., Sato M., Hirooka Y., Sakai K., Takeshita A., et al. Serum lipid profiles in japanese women and men during consumption of walnuts. Eur J Clin Nutr 2002, 56:629-637.
12. Ros E., Nunez I., Perez-Heras A., Serra M., Gilabert R., Casals E., et al. A walnut diet improves endothelial function in hypercholesterolemic subjects: a randomized crossover trial. Circulation 2004, 109:1609-1614.
13. Chen C.Y., Blumberg J.B. Phytochemical composition of nuts. Asia Pac J Clin Nutr 2008, 17:SS3329-SS3332.
14. Lopez-Uriarte P., Bullo M., Casas-Agustench P., Babio N., Salas-Salvadó J. Nuts and oxidation: a systematic review. Nutr Rev 2009, 67:497-508.
15. Schutte A.E., Van Rooyen J.M., Huisman H.W., Mukuddem-Petersen J., Oosthuizen W., Hanekom S.M., et al. Modulation of baroreflex sensitivity by walnuts versus cashew nuts in subjects with metabolic syndrome. Am J Hypertens 2006, 19:629-636.
16. Casas-Agustench P, Lopez-Uriarte P, Bullo M, Ros E, Cabre-Vila JJ, Salas-Salvadó J. Effects of one serving of mixed nuts on serum lipids, insulin resistance and inflammatory markers in patients with the metabolic syndrome. Nutr Metab Cardiovasc Dis 2009 Dec 21. [Epub ahead of print].
17. Elosua R., Marrugat J., Molina L., Pons S., Pujol E. Validation of the Minnesota leisure time physical activity questionnaire in spanish men. the MARATHOM investigators. Am J Epidemiol 1994, 139:1197-1209.
18. Cao G., Alessio H.M., Cutler R.G. Oxygen-radical absorbance capacity assay for antioxidants. Free Radic Biol Med 1993, 14:303-311.
19. Ou B., Hampsch-Woodill M., Prior R.L. Development and validation of an improved oxygen radical absorbance capacity assay using fluorescein as the fluorescent probe. J Agric Food Chem 2001, 49:4619-4626.
20. Spranger T., Finckh B., Fingerhut R., Kohlschutter A., Beisiegel U., Kontush A. How different constituents of human plasma and low density lipoprotein determine plasma oxidizability by copper. Chem Phys Lipids 1998, 91:39-52.
21. Kleinveld H.A., Hak-Lemmers H.L., Stalenhoef A.F., Demacker P.N. Improved measurement of low-density-lipoprotein susceptibility to copper-induced oxidation: application of a short procedure for isolating low-density lipoprotein. Clin Chem 1992, 38:2066-2072.
22. Brown R.K., McBurney A., Lunec J., Kelly F.J. Oxidative damage to DNA in patients with cystic fibrosis. Free Radic Biol Med 1995, 18:801-806.
23. Espinosa O., Jimenez-Almazan J., Chaves F.J., Tormos M.C., Clapes S., Iradi A., et al. Urinary 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dG), a reliable oxidative stress marker in hypertension. Free Radic Res 2007, 41:546-554.
24. Rozanski A., Qureshi E., Bauman M., Reed G., Pillar G., Diamond G.A. Peripheral arterial responses to treadmill exercise among healthy subjects and atherosclerotic patients. Circulation 2001, 103:2084-2089.
25. Hargrove R.L., Etherton T.D., Pearson T.A., Harrison E.H., Kris-Etherton P.M. Low fat and high monounsaturated fat diets decrease human low density lipoprotein oxidative susceptibility in vitro. J Nutr 2001, 131:1758-1763.
26. Hyson D.A., Schneeman B.O., Davis P.A. Almonds and almond oil have similar effects on plasma lipids and LDL oxidation in healthy men and women. J Nutr 2002, 132:703-707.
27. Jenkins D.J., Kendall C.W., Marchie A., Parker T.L., Connelly P.W., Qian W., et al. Dose response of almonds on coronary heart disease risk factors: blood lipids, oxidized low-density lipoproteins, lipoprotein(a), homocysteine, and pulmonary nitric oxide: a randomized, controlled, crossover trial. Circulation 2002, 106:1327-1332.
28. Haddad E., Jambazian P., Karunia M., Tanzman J., Sabaté J. A pecan-enriched diet increases γ-tocopherol/cholesterol and decreases thiobarbituric acid reactive substances in plasma of adults. Nutr Res 2006, 26:397-402.
29. Jia X., Li N., Zhang W., Zhang X., Lapsley K., Huang G., et al. A pilot study on the effects of almond consumption on DNA damage and oxidative stress in smokers. Nutr Cancer 2006, 54:179-183.
30. Kocyigit A., Koylu A.A., Keles H. Effects of pistachio nuts consumption on plasma lipid profile and oxidative status in healthy volunteers. Nutr Metab Cardiovasc Dis 2006, 16:202-209.
31. Li N., Jia X., Chen C.Y., Blumberg J.B., Song Y., Zhang W., et al. Almond consumption reduces oxidative DNA damage and lipid peroxidation in male smokers. J Nutr 2007, 137:2717-2722.
32. Jenkins D.J., Kendall C.W., Marchie A., Josse A.R., Nguyen T.H., Faulkner D.A., et al. Almonds reduce biomarkers of lipid peroxidation in older hyperlipidemic subjects. J Nutr 2008, 138:908-913.
33. Munoz S., Merlos M., Zambon D., Rodriguez C., Sabate J., Ros E., et al. Walnut-enriched diet increases the association of LDL from hypercholesterolemic men with human HepG2 cells. J Lipid Res 2001, 42:2069-2076.
34. Tapsell L.C., Gillen L.J., Patch C.S., Batterham M., Owen A., Bare M., et al. Including walnuts in a low-fat/modified-fat diet improves HDL cholesterol-to-total cholesterol ratios in patients with type 2 diabetes. Diabetes Care 2004, 27:2777-2783.
35. Davis L., Stonehouse W., Loots du T., Mukuddem-Petersen J., van der Westhuizen F.H., Hanekom S.M., et al. The effects of high walnut and cashew nut diets on the antioxidant status of subjects with metabolic syndrome. Eur J Nutr 2007, 46:155-164.
36. Cortes B., Nunez I., Cofan M., Gilabert R., Perez-Heras A., Casals E., et al. Acute effects of high-fat meals enriched with walnuts or olive oil on postprandial endothelial function. J Am Coll Cardiol 2006, 48:1666-1671.
37. Blomhoff R., Carlsen M.H., Andersen L.F., Jacobs D.R. Health benefits of nuts: potential role of antioxidants. Br J Nutr 2006, 96:S52-S60.
38. Anderson K.J., Teuber S.S., Gobeille A., Cremin P., Waterhouse A.L., Steinberg F.M. Walnut polyphenolics inhibit in vitro human plasma and LDL oxidation. J Nutr 2001, 131:2837-2842.
39. Sudheer A.R., Muthukumaran S., Devipriya N., Menon V.P. Ellagic acid, a natural polyphenol protects rat peripheral blood lymphocytes against nicotine-induced cellular and DNA damage in vitro: with the comparison of N-acetylcysteine. Toxicology 2007, 230:11-21.
40. Valavanidis A., Vlachogianni T., Fiotakis C. 8-hydroxy-2' -deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2009, 27:120-139.
41. Ames B.N. Endogenous oxidative DNA damage, aging and cancer. Free Radic Res Commun 1989, 7:121-128.
42. Cooke M.S., Evans M.D., Herbert K.D., Lunec J. Urinary 8-oxo-2'-deoxyguanosine: source significance and supplements. Free Radic Res 2000, 32:381-397.
43. Kalliomäki T.M., McCallum G., Wells P.G., Hill R.P. Progression and metastasis in a transgenic mouse breast cancer model: effects of exposure to in vivo hypoxia. Cancer Lett 2009, 282:98-108.
44. Oliva M.R., Ripoll F., Muñiz P., Iradi A., Trullenque R., Valls V., et al. Genetic alterations and oxidative metabolism in sporadic colorectal tumors from a Spanish community. Mol Carcinog 1997, 18:232-243.
45. Sáez G.T., Tormos C., Giner V., Chaves J., Lozano J.V., Iradi A., et al. Factors related to the impact of antihypertensive treatment in antioxidant activities and oxidative stress by-products in human hypertension. Am J Hypertens 2004, 17:809-816.
46. Martinez-Hervas S., Fandos M., Real J.T., Espinosa O., Chaves F.J., Saez G.T., et al. Insulin resistance and oxidative stress in familial combined hyperlipidemia. Atherosclerosis 2008, 199:384-389.
47. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
48. Brown A.A., Hu F.B. Dietary modulation of endothelial function: implications for cardiovascular disease. Am J Clin Nutr 2001, 73:673-686.
49. Ros E. Nuts and novel biomarkers of cardiovascular disease. Am J Clin Nutr 2009, 89:1649S-1656S.
50. Salas-Salvado J., Fernandez-Ballart J., Ros E., Martinez-Gonzalez M.A., Fito M., Estruch R., et al. Effect of a mediterranean diet supplemented with nuts on metabolic syndrome status: one-year results of the PREDIMED randomized trial. Arch Intern Med 2008, 168:2449-2458.